1. Home
  2. VOR vs TTEC Comparison

VOR vs TTEC Comparison

Compare VOR & TTEC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VOR
  • TTEC
  • Stock Information
  • Founded
  • VOR 2015
  • TTEC 1982
  • Country
  • VOR United States
  • TTEC United States
  • Employees
  • VOR N/A
  • TTEC N/A
  • Industry
  • VOR Biotechnology: Pharmaceutical Preparations
  • TTEC Retail: Computer Software & Peripheral Equipment
  • Sector
  • VOR Health Care
  • TTEC Technology
  • Exchange
  • VOR Nasdaq
  • TTEC Nasdaq
  • Market Cap
  • VOR 85.7M
  • TTEC 178.1M
  • IPO Year
  • VOR 2021
  • TTEC 1996
  • Fundamental
  • Price
  • VOR $0.16
  • TTEC $4.00
  • Analyst Decision
  • VOR Strong Buy
  • TTEC Buy
  • Analyst Count
  • VOR 7
  • TTEC 4
  • Target Price
  • VOR $9.43
  • TTEC $10.83
  • AVG Volume (30 Days)
  • VOR 943.4K
  • TTEC 257.9K
  • Earning Date
  • VOR 05-16-2025
  • TTEC 05-08-2025
  • Dividend Yield
  • VOR N/A
  • TTEC N/A
  • EPS Growth
  • VOR N/A
  • TTEC N/A
  • EPS
  • VOR N/A
  • TTEC N/A
  • Revenue
  • VOR N/A
  • TTEC $2,207,587,000.00
  • Revenue This Year
  • VOR N/A
  • TTEC N/A
  • Revenue Next Year
  • VOR N/A
  • TTEC N/A
  • P/E Ratio
  • VOR N/A
  • TTEC N/A
  • Revenue Growth
  • VOR N/A
  • TTEC N/A
  • 52 Week Low
  • VOR $0.15
  • TTEC $3.11
  • 52 Week High
  • VOR $1.87
  • TTEC $8.45
  • Technical
  • Relative Strength Index (RSI)
  • VOR 14.74
  • TTEC 53.77
  • Support Level
  • VOR $0.65
  • TTEC $3.72
  • Resistance Level
  • VOR $0.85
  • TTEC $4.07
  • Average True Range (ATR)
  • VOR 0.07
  • TTEC 0.24
  • MACD
  • VOR -0.03
  • TTEC -0.01
  • Stochastic Oscillator
  • VOR 1.88
  • TTEC 55.06

About VOR Vor Biopharma Inc.

Vor Biopharma Inc is a clinical stage cell therapy company. It combines a novel patient engineering approach with targeted therapies to provide a solution for patients suffering from hematological malignancies. The company's products include VCAR33, Tremcel and Myelodysplastic Syndrome, Trem-cel+VCAR33 Treatment System, VADC45, CD123, CLL1, EMR2.

About TTEC TTEC Holdings Inc.

TTEC Holdings Inc provides customer engagement management tools and services. The company operates through four operating segments that are organized into two groups, TTEC Digital and TTEC Engage. TTEC Digital is engaged in building and implementing cloud-based and on-premises customer experience tools that enable clients to develop customer engagement strategies. TTEC Engage focuses on delivering sales and marketing solutions to help clients boost their revenue as well as on managing customer's front-to-back office processes to optimize the customer experience. TTEC Engage contributes the vast majority of the company's revenue, and most of the sales are derived from the United States and Canada, followed by Philippines, Asia-Pacific and India.

Share on Social Networks: